Growth Metrics

Oculis Holding AG (OCS) EBT Growth (1y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 12.59%
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -148.52%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -313.33%
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 71.54%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -8.15%
8 Evaxion A 65.12 Bn 65.10 Bn - -79.57%
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 9,460.35%
10 Oculis Holding AG 24.51 Bn 24.21 Bn - -0.10%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.10%
Dec 31, 2025 10.11%
Sep 30, 2025 9.57%
Jun 30, 2025 -33.33%
Mar 31, 2025 -100.69%
Dec 31, 2024 -133.82%
Sep 30, 2024 -117,219.62%
Jun 30, 2024 -62.11%
Mar 31, 2024 62.91%
Dec 31, 2023 -47.75%
Sep 30, 2023 -92.66%
Jun 30, 2023 -11.13%